Anatara Lifesciences Ltd (ASX:ANR) Announces Australian Patent Grant for Detach
Announces Australian Patent Grant for DetachMelbourne, April 16, 2021 AEST (ABN Newswire) - Anatara Lifesciences Ltd (
ASX:ANR) is pleased to announce the grant of patent number AU2019204496 entitled Anti-diarrhea formulation which avoids antimicrobial resistance .
- Granting of patent number AU2019204496 strengthens Anatara s intellectual property position (IP) in the treatment and prevention of diarrhea caused by pathogenic microbes
- The patent provides the pathway for Anatara to further pursue commercialisation opportunities for Detach(R)
- Patent expires on 24 August 2038
- Piglet challenge study commenced
Anatara s animal heath product, Detach(R), uses the patent as a non-antibiotic approach to aid in the control of diarrheal disease (known as scour), developed using bromelain, an extract from pineapple stems.